Aug 26th 2021

Medical Oncology 101 for Health Plan Professionals

The field of medical oncology continues to advance at an accelerating pace. In 2020, the FDA approved 21 new oncology drugs, 2 biosimilars, and 36 new or expanded drug indications, for a total of 59 oncology drug approvals. Among these are some first-in-class products. The Journal of Clinical Pathways recently released a special report documenting the rapid pace of change in the field of medical oncology: “New Approved Treatments and Indications in Oncology: Highlights from 2020.”